TWAPF (TOWA Pharmaceutical Co) Interest Expense: $-15 Mil (TTM As of Mar. 2026)


TWAPF TOWA Pharmaceutical Co Ltd TWAPF
86 GF Score
Price $16.83
GF Value $15.06
! 5 Warning Signs
View Full Analysis

What is TOWA Pharmaceutical Co Interest Expense?

TOWA Pharmaceutical Co TWAPF -30.88% 86 Interest Expense is $-15 Mil as of Mar. 2026. GuruFocus rates TWAPF with a GF Score™ of 86/100 and a GF Value™ of $15.06. The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. TOWA Pharmaceutical Co's interest expense for the three months ended in Mar. 2026 was $ -4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-15 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. TOWA Pharmaceutical Co's Operating Income for the three months ended in Mar. 2026 was $ 23 Mil. TOWA Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2026 was $ -4 Mil. TOWA Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2026 was 6.23. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TOWA Pharmaceutical Co  (OTCPK:TWAPF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TOWA Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2026 was $-4 Mil. Its Operating Income for the three months ended in Mar. 2026 was $23 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $1,236 Mil.

TOWA Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*22.762/-3.655
=6.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

TOWA Pharmaceutical Co Interest Expense Historical Data

* Premium members only.

The historical data trend for TOWA Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co Interest Expense Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.94 -4.75 -6.32 -10.92 -14.25

TOWA Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.12 -3.74 -4.12 -3.41 -3.66
TWAPF
86GF Score
TOWA Pharmaceutical Co Ltd TWAPF
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TOWA Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-15 Mil mean?
TOWA Pharmaceutical Co (TWAPF) has a Interest Expense of $-15 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on TOWA Pharmaceutical Co and its competitors.
Is TOWA Pharmaceutical Co's Interest Expense too high?
TOWA Pharmaceutical Co's current Interest Expense is $-15 Mil. Overall, TOWA Pharmaceutical Co has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Interest Expense compare to ZTS and UTHR?
TOWA Pharmaceutical Co's Interest Expense of $-15 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on TOWA Pharmaceutical Co and its competitors. TOWA Pharmaceutical Co's current Interest Expense is $-15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
TOWA Pharmaceutical Co (TWAPF) has a current Interest Expense of $-15 Mil. The stock's GF Value™ is $15.06, compared to a current price of $16.83 — trading 11.8% above its estimated fair value. The current Interest Expense is $-15 Mil. TOWA Pharmaceutical Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For TOWA Pharmaceutical Co (TWAPF), the current Interest Expense is $-15 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TOWA Pharmaceutical Co (TWAPF) Overvalued in 2026?

Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued. The current stock price of $16.83 is trading 11.8% above its estimated GF Value™ of $15.06.

Key valuation signals for TWAPF:

  • Interest Expense: $-15 Mil
  • GF Value™: $15.06 vs. price of $16.83 (11.8% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the TWAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TOWA Pharmaceutical Co Business Description

Other Exchanges 4553:Japan6QC:Germany
Address 2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
86GF Score

Get the complete analysis for TWAPF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.83
Price
$15.06
GF Value